Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455 · see citing works

The cancer genome atlas pan-cancer analysis project

The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092 · see citing works

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735 · see citing works

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., TAPHOORN, M. J. B., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Bélanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,667 · see citing works

The Somatic Genomic Landscape of Glioblastoma

Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016 · see citing works

The immune contexture in human tumours: impact on clinical outcome

Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981 · see citing works

Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M. J., Obenauf, A. C., Angell, H. K., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,390 · see citing works

Immunogenic Cell Death in Cancer Therapy

Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303 · see citing works

Calreticulin exposure dictates the immunogenicity of cancer cell death

Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216 · see citing works

The prognostic landscape of genes and infiltrating immune cells across human cancers

Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., Nair, V. S., Xu, Y., Khuong, A., Hoang, C. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3909 · Cited by 3,097 · see citing works

Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · see citing works

Open source clustering software

de Hoon, M., Imoto, S., Nolan, J., & Miyano, S. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth078 · Cited by 3,043 · see citing works

Java Treeview—extensible visualization of microarray data

Saldanha, A. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth349 · Cited by 2,991 · see citing works

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

Coulie, P. G., den Eynde, B. J. V., van der Bruggen, P., & Boon, T. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3670 · Cited by 1,142 · see citing works

Dendritic-Cell-Based Therapeutic Cancer Vaccines

Palucka, K., & Banchereau, J. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.004 · Cited by 869 · see citing works

PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress

Verfaillie, T., Rubio, N., Garg, A. D., Bultynck, G., Rizzuto, R., Decuypere, J.-P., Piette, J. G., Linehan, C., Gupta, S., Afshin Samali, A., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.74 · Cited by 851 · see citing works

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.497 · Cited by 800 · see citing works

Clinical use of dendritic cells for cancer therapy

Anguille, S., Smits, E., Lion, E., Tendeloo, V. F. V., & Berneman, Z. N. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70585-0 · Cited by 707 · see citing works

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

Berghoff, A. S., Kiesel, B., Widhalm, G., Rajky, O., Ricken, G., Wöehrer, A., Dieckmann, K. U., Filipits, M., Brandstetter, A., Weller, M., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou307 · Cited by 587 · see citing works

Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide

Grossman, S. A., Ye, X., Lesser, G. J., Sloan, A. E., Carraway, H. E., Desideri, S., & Piantadosi, S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0774 · Cited by 574 · see citing works

From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancer

Angell, H., & Galon, J. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.03.004 · Cited by 574 · see citing works

Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice

Ramakrishnan, R., Assudani, D., Nagaraj, S., Hunter, T. B., Cho, H.-I., Antonia, S. J., Altiok, S., Celis, E., & Gabrilovich, D. I. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40269 · Cited by 460 · see citing works

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

Garg, A. D., Galluzzi, L., Apétoh, L., Baert, T., Birge, R. B., Pedro, J. M. B., Breckpot, K., Brough, D., Chaurio, R. A., Cirone, M., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00588 · Cited by 409 · see citing works

Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer Immunity

Dudek, A. M., Martin, S., Garg, A. D., & Agostinis, P. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00438 · Cited by 394 · see citing works

Elevated cd3+ and cd8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level

Kmiecik, J., Poli, A., Brons, N. H. C., Waha, A., Eide, G. E., Enger, P. Ø., Zimmer, J., & Chekenya, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.08.013 · Cited by 389 · see citing works

PROGgeneV2: enhancements on the existing database

Goswami, C. P., & Nakshatri, H. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-970 · Cited by 369 · see citing works

Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma

Han, S., Zhang, C., Li, Q., Dong, J., Liu, Y., Huang, Y., Jiang, T., & Wu, A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.162 · Cited by 348 · see citing works

Effector T-Cell Infiltration Positively Impacts Survival of Glioblastoma Patients and Is Impaired by Tumor-Derived TGF-β

Lohr, J., Ratliff, T., Huppertz, A., Ge, Y., Dictus, C., Ahmadi, R., Grau, S. J., Hiraoka, N., Eckstein, V., Ecker, R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2557 · Cited by 337 · see citing works

Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas

Heimberger, A. B., Abou-Ghazal, M. K., Reina-Ortiz, C., Yang, D. S., Sun, W., Qiao, W., Hiraoka, N., & Fuller, G. N. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0320 · Cited by 332 · see citing works

ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death

Garg, A. D., Dudek, A. M., Ferreira, G. B., Verfaillie, T., Vandenabeele, P., Krysko, D. V., Mathieu, C., & Agostinis, P. (2013) · Autophagy · doi:10.4161/auto.25399 · Cited by 305 · see citing works

Targeting adaptive glioblastoma: an overview of proliferation and invasion

Xie, Q. R., Mittal, S., & Berens, M. E. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou147 · Cited by 258 · see citing works

Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas

Doucette, T. A., Rao, G., Rao, A. U. K., Shen, L., Aldape, K., Wei, J., Dziurzynski, K., Gilbert, M. R., & Heimberger, A. B. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0028 · Cited by 249 · see citing works

Immunocompetent murine models for the study of glioblastoma immunotherapy

Oh, T., Fakurnejad, S., Sayegh, E. T., Clark, A., Ivan, M. E., Sun, M. Z., Safaee, M., Bloch, O. G., James, C. D., & Parsa, A. T. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-107 · Cited by 246 · see citing works

Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin‐mediated photodynamic therapy

Buytaert, E., Callewaert, G., Hendrickx, N., Scorrano, L., Hartmann, D., Missiaen, L., Vandenheede, J. R., Heirman, I., Grooten, J., & Agostinis, P. (2006) · The FASEB Journal · doi:10.1096/fj.05-4305fje · Cited by 245 · see citing works

Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis

Garg, A. D., Ruysscher, D. D., & Agostinis, P. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1069938 · Cited by 229 · see citing works

Danger signalling during cancer cell death: origins, plasticity and regulation

Garg, A. D., Martin, S., Gołąb, J., & Agostinis, P. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.48 · Cited by 225 · see citing works

Prognostic significance and mechanism of Treg infiltration in human brain tumors

Jacobs, J. F. M., Idema, A. J. S., Bol, K. F., Grotenhuis, J. A., de Vries, I. J. M., Wesseling, P., & Adema, G. J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.020 · Cited by 212 · see citing works

Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma

Han, S., Liu, Y., Li, Q., Li, Z., Hou, H., & Wu, A. (2015) · BMC Cancer · doi:10.1186/s12885-015-1629-7 · Cited by 209 · see citing works

Newcastle disease virotherapy induces long‐term survival and tumor‐specific immune memory in orthotopic glioma through the induction of immunogenic cell death

Koks, C., Garg, A. D., Ehrhardt, M., Riva, M., Vandenberk, L., Boon, L., Vleeschouwer, S. D., Agostinis, P., Graf, N. M., & Gool, S. V. (2014) · International Journal of Cancer · doi:10.1002/ijc.29202 · Cited by 206 · see citing works

Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma

Sayour, E. J., McLendon, P., McLendon, R., De Leon, G., Reynolds, R., Kresak, J., Sampson, J. H., & Mitchell, D. A. (2015) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-014-1651-7 · Cited by 196 · see citing works

MyD88: A Critical Adaptor Protein in Innate Immunity Signal Transduction

Warner, N. E., & Núñez, G. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1203103 · Cited by 185 · see citing works

CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival

Yang, I., Tihan, T., Han, S. J., Wrensch, M., Wiencke, J. K., Sughrue, M. E., & Parsa, A. T. (2010) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2010.03.031 · Cited by 181 · see citing works

Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy

Fadul, C. E., Fisher, J. L., Hampton, T. H., Lallana, E. C., Li, Z., Gui, J., Szczepiorkowski, Z. M., Tosteson, T. D., Rhodes, C. H., Wishart, H. A., et al. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318215e300 · Cited by 172 · see citing works

Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma

Wong, E. T., Lok, E., Gautam, S., & Swanson, K. D. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.238 · Cited by 152 · see citing works

CD4+CD25+FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas

Andaloussi, A. E., & Lesniak, M. S. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9314-y · Cited by 142 · see citing works

Hypericin‐induced photosensitization of HeLa cells leads to apoptosis or necrosis

Vantieghem, A., Assefa, Z., Vandenabeele, P., Declercq, W., Courtois, S. J., Vandenheede, J. R., Merlevede, W. J., de Witte, P. A. M., & Agostinis, P. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01416-1 · Cited by 135 · see citing works

Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine

Chen, H., Wang, P.-H., Chen, S.-S., Wen, C.-C., Chen, Y., Yang, W., & Yang, N. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1258-9 · Cited by 130 · see citing works

BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton

Maes, H., Eygen, S. V., Krysko, D. V., Vandenabeele, P., Nys, K., Rillaerts, K., Garg, A. D., Verfaillie, T., & Agostinis, P. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.94 · Cited by 129 · see citing works

Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy

Sengupta, S., Marrinan, J. E., Frishman, C., & Sampath, P. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/831090 · Cited by 129 · see citing works

Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study

Heimberger, A. B., Sun, W., Hussain, S. F., Dey, M., Crutcher, L. M., Aldape, K., Gilbert, M. R., Hassenbusch, S. J., Sawaya, R. A., Schmittling, B., et al. (2007) · Neuro-Oncology · doi:10.1215/15228517-2007-046 · Cited by 126 · see citing works

Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients

Fong, B., Jin, R. M., Wang, X., Safaee, M., Lisiero, D. N., Yang, I., Li, G., Liau, L. M., & Prins, R. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032614 · Cited by 109 · see citing works

DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma

Maes, W., Galicia, G., Verbinnen, B., Boon, L., Vleeschouwer, S. D., Ceuppens, J. L., & Gool, S. V. (2009) · Neuro-Oncology · doi:10.1215/15228517-2009-004 · Cited by 107 · see citing works

Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system

Ciampricotti, M., Hau, C., Doornebal, C. W., Jonkers, J., & de Visser, K. E. (2012) · Nature Medicine · doi:10.1038/nm.2652 · Cited by 104 · see citing works

Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components

Lin, T.-J., Lin, H.-T., Chang, W.-T., Pradeep Mitapalli., S., Hsiao, P., Yin, S., & Yang, N. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0435-9 · Cited by 102 · see citing works

Impact of Tumour Volume on the Potential Efficacy of Therapeutic Vaccines

Gulley, J. L., Madan, R. A., & Schlom, J. (2011) · Current Oncology · doi:10.3747/co.v18i3.783 · Cited by 102 · see citing works

Predicting the “usefulness” of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey

For the European ALA Pediatric Brain Tumor Study Group, Stummer, W., Rodrigues, F., Schucht, P., Preuß, M., Wiewrodt, D., Nestler, U., Stein, M., Artero, J. M. C., Platania, N., et al. (2014) · Acta Neurochirurgica · doi:10.1007/s00701-014-2234-2 · Cited by 101 · see citing works

Antitumor Immunity Triggered by Melphalan Is Potentiated by Melanoma Cell Surface–Associated Calreticulin

Dudek-Perić, A. M., Ferreira, G. B., Muchowicz, A., Wouters, J., Prada, N., Martin, S., Kiviluoto, S., Winiarska, M., Boon, L., Mathieu, C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2089 · Cited by 99 · see citing works

Dendritic Cell Therapy of High‐Grade Gliomas

Gool, S. V., Maes, W., Ardon, H., Verschuere, T., Cauter, S. V., & Vleeschouwer, S. D. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00316.x · Cited by 94 · see citing works

A phase II placebo-controlled study of photodynamic therapy with topical hypericin and visible light irradiation in the treatment of cutaneous T-cell lymphoma and psoriasis

Rook, A. H., Wood, G. S., Duvic, M. A., Vonderheid, E. C., Tobia, A. J., & Cabana, B. E. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.02.039 · Cited by 91 · see citing works

Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin.

Alecu, M., Ursaciuc, C., Fl, H., Coman, G., Merlevede, W. J., Waelkens, E., & de Witte, P. A. M. (1998) · PubMed · Cited by 88 · see citing works

Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal

Garg, A. D., Elsen, S., Krysko, D. V., Vandenabeele, P., de Witte, P., & Agostinis, P. (2015) · Oncotarget · doi:10.18632/oncotarget.4754 · Cited by 87 · see citing works

Glioma‐derived galectin‐1 regulates innate and adaptive antitumor immunity

Verschuere, T., Toelen, J., Maes, W., Poirier, F., Boon, L., Tousseyn, T., Mathivet, T., Gerhardt, H., Mathieu, V., Robert Kiss, A., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28426 · Cited by 85 · see citing works

NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy

Coupienne, I., Bontems, S., Dewaele, M., Rubio, N., Habraken, Y., Fulda, S., Agostinis, P., & Piette, J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.015 · Cited by 83 · see citing works

Photodynamic Therapy of Nonmelanoma Skin Cancer with Topical Hypericum perforatum Extract—A Pilot Study

Kacerovská, D., Pizinger, K., Majer, F., & Šmíd, F. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00260.x · Cited by 79 · see citing works

The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma

Yue, Q., Zhang, X., Ye, H.-X., Wang, Y., Du, Z., Yao, Y., & Mao, Y. Q. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1314-0 · Cited by 72 · see citing works

Immunological Factors Relating to the Antitumor Effect of Temozolomide Chemoimmunotherapy in a Murine Glioma Model

Kim, T., Kim, C.-H., Park, J., Park, S.-D., Kim, C. K., Chung, D., & Hong, Y.-K. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00292-09 · Cited by 72 · see citing works

Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models

Clarke, R. C. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005938428456 · Cited by 68 · see citing works

Tumour-infiltrating T-cell subpopulations in glioblastomas

Kim, Y., Jung, T., Jung, S., Jang, W., Moon, K., Kim, I., Lee, M. C., & Lee, J. (2011) · British Journal of Neurosurgery · doi:10.3109/02688697.2011.584986 · Cited by 68 · see citing works

Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme

Hunn, M. K., Bauer, E., Wood, C. E., Gasser, O., Dzhelali, M., Ancelet, L. R., Mester, B., SHARPLES, K. J., Findlay, M. P. N., Hamilton, D. A., et al. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1635-7 · Cited by 64 · see citing works

Dendritic Cell–Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma

Dey, M., Chang, A. L., Miska, J. M., Wainwright, D. A., Ahmed, A. U., Balyasnikova, I. V., Pytel, P., Han, Y., Tobias, A. L., Zhang, L., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401607 · Cited by 63 · see citing works

Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma

Vandenberk, L., Garg, A. D., Verschuere, T., Koks, C., Belmans, J., Beullens, M., Agostinis, P., Vleeschouwer, S. D., & Gool, S. V. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1083669 · Cited by 57 · see citing works

Enhanced antitumour immunity by combined use of temozolomide and TAT‐survivin pulsed dendritic cells in a murine glioma

Kim, C., Woo, S., Park, J., Kim, H., Park, M., Park, S., Hong, Y., & Kim, T. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02680.x · Cited by 55 · see citing works

Regulatory T cells are not a strong predictor of survival for patients with glioblastoma

Thomas, A. A., Fisher, J. L., Rahme, G. J., Hampton, T. H., Baron, U., Olek, S., Schwachula, T., Rhodes, C. H., Gui, J., Tafe, L. J., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou363 · Cited by 52 · see citing works

Clinical Efficacy of Tumor Antigen-Pulsed DC Treatment for High-Grade Glioma Patients: Evidence from a Meta-Analysis

Cao, J., Zhang, X.-Y., Liu, J.-L., Li, D., Li, J., Liu, Y.-S., Wang, M., Xu, B., Wang, H., & Wang, Z.-X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107173 · Cited by 44 · see citing works

Hypericin for visualization of high grade gliomas: First clinical experience

Ritz, R., Daniels, R., Noell, S., Feigl, G. C., Schmidt, V., Bornemann, A., Ramina, K. F., Mayer, D., Dietz, K., Strauß, W. S. L., et al. (2012) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.12.021 · Cited by 43 · see citing works

Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies

Stoll, G., Bindea, G., Mlecnik, B., Galon, J., Zitvogel, L., & Kroemer, G. (2015) · Oncotarget · doi:10.18632/oncotarget.4180 · Cited by 41 · see citing works

Analysis of CD137L and IL-17 Expression in Tumor Tissue as Prognostic Indicators for Gliblastoma

Cui, X., Xu, Z., Zhao, Z., Sui, D., Ren, X., Huang, Q., Qin, J., Hao, L., Wang, Z., Shen, L., et al. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.4891 · Cited by 37 · see citing works

Epigenetic biomarkers of T-cells in human glioma

Wiencke, J. K., Accomando, W. P., Zheng, S., Patoka, J., Dou, X., Phillips, J. J., Hsuang, G., Christensen, B. C., Houseman, E. A., Koestler, D. C., et al. (2012) · Epigenetics · doi:10.4161/epi.22675 · Cited by 36 · see citing works

Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells

Eyrich, M. K., Schreiber, S. C., Rachor, J., Krauß, J., Pauwels, F., Hain, J., Wölfl, M., Lutz, M. B., Vleeschouwer, S. D., Schlegel, P. G., et al. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.02.017 · Cited by 34 · see citing works

Foxp3+ regulatory T cells are activated in spite of B7‐CD28 and CD40‐CD40L blockade

Vogel, I., Verbinnen, B., Maes, W., Boon, L., Gool, S. W. V., & Ceuppens, J. L. (2013) · European Journal of Immunology · doi:10.1002/eji.201242737 · Cited by 31 · see citing works

Active dendritic cell immunotherapy for glioblastoma: Current status and challenges

Polyzoidis, S., Tuazon, J., Brazil, L., Beaney, R. P., Al‐Sarraj, S., Doey, L. J., Logan, J., Hurwitz, V., Jarosz, J., Bhangoo, R. S., et al. (2014) · British Journal of Neurosurgery · doi:10.3109/02688697.2014.994473 · Cited by 24 · see citing works

Iatrogenic immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide: A NABTT CNS Consortium study.

Grossman, S. A., Ye, X., Lesser, G. J., Sloan, A. E., Carson, C., & Piantadosi, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.2013 · Cited by 9 · see citing works

Prognostic value of the preoperative immunological profile in patients with glioblastoma

Gousias, K., Voulgaris, S., Vartholomatos, G., Voulgari, P. V., Kyritsis, A. P., & Markou, M. (2014) · Surgical Neurology International · doi:10.4103/2152-7806.134104 · Cited by 8 · see citing works

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.

Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works

Dendritic cells in cancer immunology and immunotherapy

Wculek, S. K., Cueto, F. J., Mujal, A. M., Melero, I., Krummel, M. F., & Sancho, D. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0210-z · Cited by 2,594 · see citing works

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

Fukumura, D., Kloepper, J., Amoozgar, Z., Duda, D. G., & Jain, R. K. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.29 · Cited by 2,027 · see citing works

The Microenvironmental Landscape of Brain Tumors

Quail, D. F., & Joyce, J. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.009 · Cited by 1,875 · see citing works

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

Galluzzi, L., Humeau, J., Buqué, A., Zitvogel, L., & Kroemer, G. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0413-z · Cited by 1,349 · see citing works

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Galluzzi, L., Vitale, I., Warren, S., Adjemian, S., Agostinis, P., Buqué, A., Chan, T. A.-T., Coukos, G., Demaria, S., Deutsch, É., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000337 · Cited by 1,151 · see citing works

Dendritic cell-based immunotherapy

Sabado, R. L., Balan, S., & Bhardwaj, N. (2016) · Cell Research · doi:10.1038/cr.2016.157 · Cited by 926 · see citing works

Immunogenic cell death in cancer therapy: Present and emerging inducers

Zhou, J., Wang, G., Chen, Y., Wang, H., Hua, Y., & Cai, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14356 · Cited by 715 · see citing works

Defining the role of the tumor vasculature in antitumor immunity and immunotherapy

Schaaf, M. B., Garg, A. D., & Agostinis, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0061-0 · Cited by 629 · see citing works

Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future

Alzeibak, R., Mishchenko, T. A., Shilyagina, N. Y., Владимировна, Б. И., Vedunova, M. V., & Krysko, D. V. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001926 · Cited by 579 · see citing works

Targeting immunogenic cell stress and death for cancer therapy

Galluzzi, L., Guilbaud, E., Schmidt, D. R., Kroemer, G., & Marincola, F. M. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00920-9 · Cited by 595 · see citing works

Massively Evoking Immunogenic Cell Death by Focused Mitochondrial Oxidative Stress using an AIE Luminogen with a Twisted Molecular Structure

Chen, C., Ni, X., Jia, S., Liang, Y., Wu, X., Kong, D., & Ding, D. (2019) · Advanced Materials · doi:10.1002/adma.201904914 · Cited by 503 · see citing works

Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity

Donohoe, C. L., Senge, M. O., Arnaut, L. G., & Gomes-da-Silva, L. C. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.07.003 · Cited by 444 · see citing works

Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses

Garg, A. D., & Agostinis, P. (2017) · Immunological Reviews · doi:10.1111/imr.12574 · Cited by 448 · see citing works

Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer

Huang, L., Rong, Y., Tang, X., Yi, K., Qi, P., Hou, J., Liu, W., He, Y. Z., Gao, X., Yuan, C., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01515-x · Cited by 413 · see citing works

Photodynamic Therapy for the Treatment and Diagnosis of Cancer–A Review of the Current Clinical Status

Gunaydin, G., Gedik, M. E., & Ayan, S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.686303 · Cited by 402 · see citing works

A melanin-mediated cancer immunotherapy patch

Ye, Y., Wang, C., Zhang, X., Hu, Q., Zhang, Y., Liu, Q., Wen, D., Milligan, J. J., Bellotti, A., Huang, L., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan5692 · Cited by 382 · see citing works

Pathological Mechanism of Photodynamic Therapy and Photothermal Therapy Based on Nanoparticles

Hou, Y., Yang, X., Liu, R., Zhao, D., Guo, C., Zhu, A., Wen, M., Liu, Z., Qu, G., & Meng, H. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s269321 · Cited by 351 · see citing works

Integrating next-generation dendritic cell vaccines into the current cancer immunotherapy landscape

Garg, A. D., Coulie, P. G., Van den Eynde, B. J., & Agostinis, P. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.05.006 · Cited by 340 · see citing works

Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication

Song, W. L., Kuang, J., Li, C., Zhang, M., Zheng, D., Zeng, X., Liu, C., & Zhang, X. (2018) · ACS Nano · doi:10.1021/acsnano.7b09112 · Cited by 313 · see citing works

Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics

Garg, A. D., More, S., Rufo, N., Meçe, O., Sassano, M. L., Agostinis, P., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1386829 · Cited by 277 · see citing works

Antitumour dendritic cell vaccination in a priming and boosting approach

Harari, A., Graciotti, M., Bassani‐Sternberg, M., & Kandalaft, L. E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0074-8 · Cited by 271 · see citing works

Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy

Sánchez-Paulete, A. R., Teijeira, Á., Cueto, F. J., Garasa, S., Perez‐Gracia, J. L., Sánchez-Arráez, Á., Sancho, D., & Melero, I. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx237 · Cited by 267 · see citing works

A Polymer Multicellular Nanoengager for Synergistic NIR‐II Photothermal Immunotherapy

Xu, C., Jiang, Y., Han, Y., Pu, K., & Zhang, R. (2021) · Advanced Materials · doi:10.1002/adma.202008061 · Cited by 235 · see citing works

β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion

Du, L., Lee, J., Jiang, H., Wang, C., Wang, S., Zheng, Z., Shao, F., Xu, D., Xia, Y., Li, J., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191115 · Cited by 230 · see citing works

Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology

Vanmeerbeek, I., Sprooten, J., Ruysscher, D. D., Tejpar, S., Vandenberghe, P., Fucikova, J. P., Špíšek, R., Zitvogel, L., Kroemer, G., Galluzzi, L., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2019.1703449 · Cited by 226 · see citing works

The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy

Rufo, N., Garg, A. D., & Agostinis, P. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.07.002 · Cited by 211 · see citing works

Origin and Consequences of Necroinflammation

Sarhan, M., Land, W. G., Tonnus, W., Hugo, C., & Linkermann, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00041.2016 · Cited by 210 · see citing works

Immunotherapy for glioblastoma: the promise of combination strategies

Bausart, M., Véronique Préat, A., & Malfanti, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02251-2 · Cited by 201 · see citing works

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma

del Valle, A. S., Anel, A., Naval, J., & Marzo, I. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00050 · Cited by 196 · see citing works

Photodynamic Therapy and Immunity: An Update

Falk‐Mahapatra, R., & Gollnick, S. O. (2020) · Photochemistry and Photobiology · doi:10.1111/php.13253 · Cited by 195 · see citing works

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas

Amoozgar, Z., Kloepper, J., Ren, J. P., Tay, R. E., Kazer, S. W., Kiner, E., Krishnan, S., Posada, J. M., Ghosh, M., Mamessier, É., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22885-8 · Cited by 194 · see citing works

Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy

Medrano, R. F. V., Hunger, A., Mendonça, S. A., Barbuto, J. A. M., & Strauss, B. E. (2017) · Oncotarget · doi:10.18632/oncotarget.19531 · Cited by 185 · see citing works

Necroptosis in Immuno-Oncology and Cancer Immunotherapy

Sprooten, J., Wijngaert, P. D., Vanmeerbeek, I., Martin, S., Vangheluwe, P., Schlenner, S., Krysko, D. V., Parys, J. B., Bultynck, G., Vandenabeele, P., et al. (2020) · Cells · doi:10.3390/cells9081823 · Cited by 169 · see citing works

Current Challenges and Opportunities of Photodynamic Therapy against Cancer

Huis in ‘t Veld, R. V., Heuts, J., Ma, S., Cruz, L. J., Ossendorp, F. A., & Jager, M. J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020330 · Cited by 159 · see citing works

Research progress on morphology and mechanism of programmed cell death

Chen, Y., Li, X., Yang, M., & Liu, S. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06712-8 · Cited by 160 · see citing works

Covalent Organic Framework‐Supported Molecularly Dispersed Near‐Infrared Dyes Boost Immunogenic Phototherapy against Tumors

Gan, S., Tong, X., Zhang, Y., Wu, J., Hu, Y., & Yuan, A. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201902757 · Cited by 152 · see citing works

Trial watch: dendritic cell vaccination for cancer immunotherapy

Sprooten, J., Ceusters, J., Coosemans, A., Agostinis, P., Vleeschouwer, S. D., Zitvogel, L., Kroemer, G., Galluzzi, L., & Garg, A. D. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1638212 · Cited by 148 · see citing works

The Course of Immune Stimulation by Photodynamic Therapy: Bridging Fundamentals of Photochemically Induced Immunogenic Cell Death to the Enrichment of T‐Cell Repertoire

Nath, S., Obaid, G., & Hasan, T. G. (2019) · Photochemistry and Photobiology · doi:10.1111/php.13173 · Cited by 144 · see citing works

Endoplasmic reticulum targeted AIE bioprobe as a highly efficient inducer of immunogenic cell death

Li, J., Gao, H., Liu, R., Chen, C., Zeng, S., Liu, Q., & Ding, D. (2020) · Science China Chemistry · doi:10.1007/s11426-020-9846-4 · Cited by 142 · see citing works

Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy

Woensel, M. V., Mathivet, T., Wauthoz, N., Rosière, R., Garg, A. D., Agostinis, P., Mathieu, V., Robert Kiss, A., Lefranc, F., Boon, L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01279-1 · Cited by 140 · see citing works

Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: an update review

Zhai, J., Gu, X., Liu, Y., Hu, Y., Jiang, Y., & Zhang, Z. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1152934 · Cited by 131 · see citing works

Type I interferons and dendritic cells in cancer immunotherapy

(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.06.001 · Cited by 124 · see citing works

Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development

Montico, B., Nigro, A., Casolaro, V., & Col, J. D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020594 · Cited by 128 · see citing works

PPARG-mediated ferroptosis in dendritic cells limits antitumor immunity

Han, L., Bai, L., Qu, C., Dai, E., Liu, J., Kang, R., Zhou, D., Tang, D., & Zhao, Y. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.08.082 · Cited by 128 · see citing works

Photo-activated chemo-immunotherapy for metastatic cancer using a synergistic graphene nanosystem

Zhou, F., Wang, M., Luo, T., Qu, J., & Chen, W. R. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120421 · Cited by 124 · see citing works

Pathogen response-like recruitment and activation of neutrophils by sterile immunogenic dying cells drives neutrophil-mediated residual cell killing

Garg, A. D., Vandenberk, L., Fang, S., Fasche, T., Van Eygen, S., Maes, J., Van Woensel, M., Koks, C., Vanthillo, N., Graf, N., et al. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.15 · Cited by 120 · see citing works

Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus

Gomes-da-Silva, L. C., Zhao, L., Bezu, L., Zhou, H., Sauvat, A., Liu, P., Durand, S., Leduc, M., Souquère, S., Loos, F., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798354 · Cited by 118 · see citing works

Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells

Loenhout, J. V., Flieswasser, T., Boullosa, L. F., Waele, J. D., Audenaerde, J. R. M. V., Marcq, E., Jacobs, J., Lin, A. G., Lion, E., Dewitte, H., et al. (2019) · Cancers · doi:10.3390/cancers11101597 · Cited by 118 · see citing works

Trial watch: Dendritic cell-based anticancer immunotherapy

Garg, A. D., Vara‐Pérez, M., Schaaf, M. B. E., Agostinis, P., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1328341 · Cited by 117 · see citing works

Therapeutic cancer vaccines: From initial findings to prospects

Song, Q., Zhang, C.-D., & Wu, X.-H. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.011 · Cited by 106 · see citing works

The network of immunosuppressive pathways in glioblastoma

Mangani, D., Weller, M., & Roth, P. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.12.011 · Cited by 103 · see citing works

Local Phototherapy Synergizes with Immunoadjuvant for Treatment of Pancreatic Cancer through Induced Immunogenic Tumor Vaccine

Zhou, F., Yang, J., Zhang, Y., Liu, M., Lang, M. L., Li, M., & Chen, W. R. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1126 · Cited by 102 · see citing works

Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End

Datsi, A., & Sorg, R. V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.770390 · Cited by 102 · see citing works

Radiation‐Induced Immunogenic Cell Death for Cancer Radioimmunotherapy

Liu, T., Pei, P., Shen, W., Hu, L. T., & Yang, K. (2023) · Small Methods · doi:10.1002/smtd.202201401 · Cited by 100 · see citing works

Trial watch: chemotherapy-induced immunogenic cell death in oncology

Sprooten, J., Laureano, R. S., Vanmeerbeek, I., Govaerts, J., Naulaerts, S., Borràs, D., Kinget, L., Fucikova, J. P., Špíšek, R., Jelinkova, L. P., et al. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2219591 · Cited by 100 · see citing works

Decoding immunogenic cell death from a dendritic cell perspective

Janssens, S., Rennen, S., & Agostinis, P. (2023) · Immunological Reviews · doi:10.1111/imr.13301 · Cited by 101 · see citing works

Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity

Lamberti, M. J., Nigro, A., Mentucci, F. M., Vittar, N. B. R., Casolaro, V., & Col, J. D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030256 · Cited by 95 · see citing works

Engineering challenges for brain tumor immunotherapy

Lyon, J. G., Mokarram, N., Saxena, T. K., Carroll, S. L., & Bellamkonda, R. V. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.006 · Cited by 96 · see citing works

Boosting Tumor-Specific Immunity Using PDT

Maeding, N., Verwanger, T., & Krammer, B. E. (2016) · Cancers · doi:10.3390/cancers8100091 · Cited by 94 · see citing works

Cancer photo-immunotherapy: from bench to bedside

Wang, M., Rao, J., Wang, M., Li, X., Liu, K., Naylor, M. F., Nordquist, R. E., Chen, W. R., & Zhou, F. (2020) · Theranostics · doi:10.7150/thno.53056 · Cited by 91 · see citing works

Cyclic Amplification of the Afterglow Luminescent Nanoreporter Enables the Prediction of Anti‐cancer Efficiency

Wang, Y., Song, G., Liao, S., Qin, Q., Zhao, Y., Shi, L., Guan, K., Gong, X., Wang, P., Yin, X., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202104127 · Cited by 91 · see citing works

Advances in immunotherapeutic research for glioma therapy

Miyauchi, J. T., & Tsirka, S. E. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8695-5 · Cited by 90 · see citing works

Glioblastoma vaccines: past, present, and opportunities

Xiong, Z., Raphael, I., Olin, M. R., Okada, H., Li, X., & Kohanbash, G. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2023.104963 · Cited by 90 · see citing works

Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation.

Li, H.-N., Luo, Q., Zhang, H., Ma, X.-L., Gu, Z., Gong, Q.-Y., & Luo, K. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00437b · Cited by 52 · see citing works

BSA‐AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma

Liu, Z., Zhang, J., Liu, H., Shen, H., Meng, N., Qi, X., Ding, K., Song, J., Fu, R., Ding, D., et al. (2022) · Advanced Materials · doi:10.1002/adma.202208692 · Cited by 86 · see citing works

Type I interferons and endoplasmic reticulum stress in health and disease

(2020) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.10.004 · Cited by 83 · see citing works

Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy

Yang, Q., Shi, G., Chen, X., Lin, Y., Cheng, L., Jiang, Q., Yan, X., Jiang, M., Li, Y., Zhang, H., et al. (2020) · Theranostics · doi:10.7150/thno.45391 · Cited by 81 · see citing works

Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot

Li, Z., Zhu, L., Sun, H., Shen, Y., Hu, D., Wu, W., Wang, Y., Qian, C., & Sun, M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011297117 · Cited by 81 · see citing works

Bifunctional cancer cell–based vaccine concomitantly drives direct tumor killing and antitumor immunity

Chen, K., Reinshagen, C., van Schaik, T., Rossignoli, F., Borges, P., Mendonca, N. C., Abdi, R., Simon, B. G., Reardon, D. A., Wakimoto, H., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo4778 · Cited by 80 · see citing works

Nanoparticle-Mediated CD47-SIRPα Blockade and Calreticulin Exposure for Improved Cancer Chemo-Immunotherapy

Luo, J., Liu, R., Chen, F., Zhang, J., Zheng, S.-J., Shao, D., & Du, J. (2023) · ACS Nano · doi:10.1021/acsnano.2c08240 · Cited by 79 · see citing works

Photodynamic Modulation of Endoplasmic Reticulum and Mitochondria Network Boosted Cancer Immunotherapy

Wang, X., Qian, J., Yang, Z., Song, Y., Pan, W., Ye, Y., Qin, X., Yan, X., Huang, X., Wang, X., et al. (2023) · Advanced Materials · doi:10.1002/adma.202310964 · Cited by 79 · see citing works

Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better

Thiruppathi, J., Vijayan, V., Park, I., Lee, S. E., & Rhee, J. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1375767 · Cited by 81 · see citing works

Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis

Krenzlin, H., Behera, P., Lorenz, V., Passaro, C., Zdioruk, M. I., Nowicki, M. O., Grauwet, K., Zhang, H., Skubal, M., Ito, H., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123375 · Cited by 78 · see citing works

Photodynamic therapy regulates fate of cancer stem cells through reactive oxygen species

Zhang, Z., Wang, K., Mo, J., Xiong, L., & Wen, Y. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i7.562 · Cited by 78 · see citing works

DAMP—Induced Allograft and Tumor Rejection: The Circle Is Closing

Land, W. G., Agostinis, P., Gasser, S., Garg, A. D., & Linkermann, A. (2016) · American Journal of Transplantation · doi:10.1111/ajt.14012 · Cited by 78 · see citing works

Large Amino Acid Transporter 1 Selective Liposomes of l -DOPA Functionalized Amphiphile for Combating Glioblastoma

Bhunia, S., Vangala, V., Bhattacharya, D., Ravuri, H. G., Kuncha, M., Chakravarty, S., Sistla, R., & Chaudhuri, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00569 · Cited by 77 · see citing works

Current advances in temozolomide encapsulation for the enhancement of glioblastoma treatment

Iturrioz-Rodríguez, N., Samprón, N., & Matheu, A. (2023) · Theranostics · doi:10.7150/thno.82005 · Cited by 77 · see citing works

Tumor‐Activated Size‐Enlargeable Bioinspired Lipoproteins Access Cancer Cells in Tumor to Elicit Anti‐Tumor Immune Responses

Li, J., Wang, H., Wang, Y., Gong, X., Xu, X., Sha, X., Zhang, A., Zhang, Z., & Li, Y. (2020) · Advanced Materials · doi:10.1002/adma.202002380 · Cited by 73 · see citing works

Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma

Garg, A. D., Vandenberk, L., Woensel, M. V., Belmans, J., Schaaf, M. B. E., Boon, L., Vleeschouwer, S. D., & Agostinis, P. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1295903 · Cited by 71 · see citing works

Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma

Decraene, B., Yang, Y., Smet, F. D., Garg, A. D., Agostinis, P., & Vleeschouwer, S. D. (2022) · Genes and Immunity · doi:10.1038/s41435-021-00161-5 · Cited by 70 · see citing works

Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma

Hargadon, K. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01594 · Cited by 68 · see citing works

In Situ Attached Photothermal Immunomodulation-Enhanced Nanozyme for the Inhibition of Postoperative Malignant Glioma Recurrence

Nie, D., Ling, Y., Lv, W., Liu, Q., Deng, S., Shi, J., Yang, J., Yang, Y., Ouyang, S., Huang, Y., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c03696 · Cited by 65 · see citing works

Low Photosensitizer Dose and Early Radiotherapy Enhance Antitumor Immune Response of Photodynamic Therapy-Based Dendritic Cell Vaccination

Doix, B., Trempolec, N., Riant, O., & Féron, O. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00811 · Cited by 65 · see citing works

Strategies for developing and optimizing cancer vaccines

Maeng, H. M., & Berzofsky, J. A. (2019) · F1000Research · doi:10.12688/f1000research.18693.1 · Cited by 64 · see citing works

Exosomes derived from rAAV/AFP-transfected dendritic cells elicit specific T cell-mediated immune responses against hepatocellular carcinoma

Li, J., Huang, S., Zhou, Z., Lin, W., Chen, S., Chen, M., & Ye, Y. (2018) · Cancer Management and Research · doi:10.2147/cmar.s178326 · Cited by 61 · see citing works

Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?

Stepanenko, A. A., & Chekhonin, V. P. (2018) · Cancers · doi:10.3390/cancers10120492 · Cited by 60 · see citing works

Molecular determinants of immunogenic cell death elicited by radiation therapy

Galassi, C., Klapp, V., Yamazaki, T., & Galluzzi, L. (2023) · Immunological Reviews · doi:10.1111/imr.13271 · Cited by 63 · see citing works

Cancer vaccines: platforms and current progress

Lei, W., Zhou, K., Lei, Y., Qiu, L., & Zhu, H. (2025) · Molecular Biomedicine · doi:10.1186/s43556-024-00241-8 · Cited by 62 · see citing works

Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy

Montico, B., Lapenta, C., Ravo, M., Martorelli, D., Muraro, E., Zeng, B., Comaro, E., Spada, M., Donati, S., Santini, S. M., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1356964 · Cited by 57 · see citing works

Natural compound inducers of immunogenic cell death

Diederich, M. F. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01150-z · Cited by 58 · see citing works

Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer

Flieswasser, T., Loenhout, J. V., Boullosa, L. F., Eynde, A. V. D., Waele, J. D., Audenaerde, J. V. V., Lardon, F., Smits, E., Pauwels, P., & Jacobs, J. (2020) · Cells · doi:10.3390/cells9061474 · Cited by 50 · see citing works

Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy

Su, Z., Xiao, Z., Huang, J., Wang, Y., An, Y., Xiao, H. P., Peng, Y., Pang, P., Han, S., Zhu, K., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c20422 · Cited by 57 · see citing works

Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells

Sprooten, J., Vanmeerbeek, I., Datsi, A., Govaerts, J., Naulaerts, S., Laureano, R. S., Borràs, D., Calvet, A., Malviya, V., Kuballa, M., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101377 · Cited by 59 · see citing works

Phytochemicals Approach for Developing Cancer Immunotherapeutics

Yin, S.-Y., Yang, N.-S., & Lin, T.-J. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00386 · Cited by 57 · see citing works

The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells

Xie, W., Zhu, S., Yang, B., Chen, C., Chen, S., Liu, Y., Nie, X., Hao, L., Wang, Z., Sun, J., et al. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s208404 · Cited by 56 · see citing works

Synthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancer

Szymańska, E., Nowak, P., Kolmus, K., Cybulska, M., Goryca, K., Derezińska‐Wołek, E., Szumera‐Ciećkiewicz, A., Brewińska‐Olchowik, M., Grochowska, A., Piwocka, K., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910812 · Cited by 56 · see citing works

Clinical implication of cellular vaccine in glioma: current advances and future prospects

Yan, Y., Zeng, S., Gong, Z., & Xu, Z. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01778-6 · Cited by 56 · see citing works

Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor

Jiang, Q., Zhang, C., Wang, H., Peng, T., Li, Z., Wang, Y., Han, W., & Shi, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01196 · Cited by 55 · see citing works

Hypericin: A natural anthraquinone as promising therapeutic agent

Wu, J., Zhang, J., Xia, C., Ding, K., Li, X., Pan, X.-G., Xu, J., He, J., & Zhang, W. K. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154654 · Cited by 54 · see citing works

Next-generation immunogenic dendritic cell vaccines achieve a danger signaling and T cell-driven eradication of high-grade glioma

Garg, A., Vandenberk, L., Koks, C., Verschuere, T., Gool, S. V., & Agostinis, P. (2016) · Klinische Pädiatrie · doi:10.1055/s-0036-1593558

Irradiation of necrotic tumor cells used to pulse dendritic cells (DCs) potentiates DC vaccine-induced anti-tumor immunity in a mouse model of high-grade glioma

Vandenberk, L., Garg, A. D., Agostinis, P., Verschuere, T., Koks, C., Vleeschouwer, S. D., & Gool, S. V. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-s3-p163 · Cited by 1 · see citing works

Targeting immunogenic cell death for glioma immunotherapy

Mishchenko, T. A., Turubanova, V. D., Gorshkova, E. N., Krysko, O., Vedunova, M. V., & Krysko, D. V. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.10.005 · Cited by 15 · see citing works

Immunogene op oxidatietherapie-gebaseerde tweede generatie dendritische celvaccins voor de behandeling van hooggradige gliomen

Vandenberk, L. (2016) · Lirias

Approaches to Improve Efficiency of Dendritic Cell-based Therapy of High Grade Gliomas

Chistiakov, D. A., Chekhonin, I. V., Gurina, O. I., Bobryshev, Y. V., & Chekhonin, V. P. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160719110618 · Cited by 7 · see citing works